Philip Krause, MD, MS, MBA is the reason MSB is getting an opportunity to resubmit the BLA he is potentially worth a billion dollars to this company as he was able to overcome SI's lack of experience with the FDA. The BLA will be resubmitted professionally and hopefully the FDA will make the first platform approval for MSB in the next few months. Col69 try to be a mature adult when posting
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-954
-
- There are more pages in this discussion • 143 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
-0.105(8.37%) |
Mkt cap ! $1.313B | |||
| Open | High | Low | Value | Volume |
| $1.22 | $1.23 | $1.14 | $9.583M | 8.106M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 25000 | 2 |
View Market Depth
| Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |